Adding lomustine to the standard combination of idarubicin and cytarabine for the treatment of old patients with acute myeloid leukemia improves complete response rates and overall survival. These ...
PALO ALTO, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Orbus Therapeutics, Inc., a private pharmaceutical company, today announced that the combination of eflornithine and lomustine achieved a ...
People diagnosed with recurrent IDH-mutant grade 3 astrocytoma, a rare and aggressive brain cancer, lived roughly 11 months ...
Review the side-effects of Lomustine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...
Access the segment here HOUSTON, TX / ACCESS Newswire / June 8, 2026 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the ... · ACCESS Newswire · CNS Pharmaceuticals, Inc. "Berubicin is being ...
Reiterative Survival Analyses of Total Therapy 2 for Multiple Myeloma Elucidate Follow-Up Time Dependency of Prognostic Variables and Treatment Arms In order to evaluate the impact of lomustine in a ...
Bevacizumab is approved for the treatment of patients with progressive glioblastoma on the basis of uncontrolled data. Data from a phase 2 trial suggested that the addition of bevacizumab to lomustine ...
Further Evaluation of Intensified and Increased Total Dose of Cyclophosphamide for the Treatment of Primary Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-25 ...
Please provide your email address to receive an email when new articles are posted on . The addition of lomustine to bevacizumab failed to confer a survival advantage for the treatment of progressive ...
TUESDAY, Dec. 16, 2025 (HealthDay News) -- For patients with recurrent grade 3 astrocytoma, clinically meaningful improvements were seen for eflornithine + lomustine versus lomustine monotherapy, ...
Details concerning the Lomustine medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and injections.